Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
The Journal of the Royal Society for the Promotion of Health
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Pandita-Gunawardena, R.
Right arrow Articles by Donaldson, D.
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Decreasing requirement for lithium carbonate therapy in bipolar affective disorder (hypomanic type) following the onset of chronic renal insufficiency

R. Pandita-Gunawardena

East Surrey Hospital, Redhill, Surrey, Horley Community Mental Health Team and Day Unit, Beechcroft, Horley, Surrey

D. Donaldson

East Surrey Hospital, Redhill, Surrey, Crawley Hospital, Crawley, West Sussex

The importance of regular monitoring of both serum lithium and creatinine levels, together with thyroid function assessment, in a patient taking lithium carbonate therapy for bipolar affective disorder (hypomanic type) is emphasised. In this case it was the gradual rise of serum creatinine that alerted the physician to the onset of insidiously progressive renal impairment. In the absence of any evidence for another aetiology, it was concluded that a possible cause for the renal problem was the lithium therapy itself. By reducing the dosage it was found that serum lithium levels were maintained within the reference range, thus avoiding the potential psychiatric consequences of high concentrations — which could well have occurred had the former dosage been continued during the period of deteriorating renal function. The situation is currently being carefully monitored in case another cause for renal disease, other than that of a side-effect of therapy, emerges at a later date.

Key Words: Bipolar affective disorder (hypomanic type) • dosage reduction • lithium therapy • lithium toxicity • renal insufficiency

The Journal of the Royal Society for the Promotion of Health, Vol. 118, No. 1, 35-39 (1998)
DOI: 10.1177/146642409811800108


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?